{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:18:24Z","timestamp":1788905904717,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department for the Environment Food and Agricultural Affairs","award":["SE4109"],"award-info":[{"award-number":["SE4109"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T01:16:24Z","timestamp":1492823784000},"page":"6024-6029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicola Mary","family":"Manning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Bachanek-Bankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul Clement","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Castillo-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.005_b0005","unstructured":"Coetzer JAWG, A. J. African horse sickness. In: Tustin. JAWCRC, editor. Infectious diseases of livestock. 2nd ed. Cape Town, Southern Africa: Oxford University Press; 2004. p. 1231\u201346."},{"key":"10.1016\/j.vaccine.2017.04.005_b0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1051\/vetres:2004021","article-title":"African horse sickness","volume":"35","author":"Mellor","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0015","doi-asserted-by":"crossref","first-page":"e25697","DOI":"10.1371\/journal.pone.0025697","article-title":"Detection of a fourth orbivirus non-structural protein","volume":"6","author":"Belhouchet","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.04.005_b0020","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1128\/JVI.00517-12","article-title":"Structural insight into African horsesickness virus infection","volume":"86","author":"Manole","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.04.005_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01249302","article-title":"Characterization of African horsesickness virus","volume":"29","author":"Oellermann","year":"1970","journal-title":"Arch Gesamte Virusforsch"},{"key":"10.1016\/j.vaccine.2017.04.005_b0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0147-9571(94)90046-9","article-title":"African horse sickness virus structure","volume":"17","author":"Roy","year":"1994","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.005_b0035","first-page":"235","article-title":"Structural studies of orbivirus particles","volume":"14","author":"Stuart","year":"1998","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2017.04.005_b0040","first-page":"175","article-title":"On the relationship between bluetongue, African horsesickness and reoviruses: hybridization studies","volume":"36","author":"Verwoerd","year":"1969","journal-title":"Onderstepoort J Veterinary Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0045","first-page":"113","article-title":"The Culicoides vectors of African horse sickness virus in Morocco: distribution and epidemiological implications","volume":"14","author":"Bouayoune","year":"1998","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2017.04.005_b0050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0950268899002897","article-title":"African horse sickness in Portugal: a successful eradication programme","volume":"123","author":"Portas","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.04.005_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-1135(92)90041-Q","article-title":"African horse sickness in Spain","volume":"33","author":"Rodriguez","year":"1992","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2017.04.005_b0060","first-page":"255","article-title":"Control and eradication of African horse sickness with vaccine","volume":"119","author":"Sanchez-Vizcaino","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2017.04.005_b0065","first-page":"697","article-title":"The attenuation of viscerotropic horsesickness virus in tissue culture","volume":"64","author":"Erasmus","year":"1965","journal-title":"Bulletin \u2013 Office international des epizooties"},{"key":"10.1016\/j.vaccine.2017.04.005_b0070","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.vaccine.2010.06.105","article-title":"In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6","volume":"28","author":"von Teichman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0075","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1016\/j.vaccine.2008.07.037","article-title":"Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals","volume":"26","author":"von Teichman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0080","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3201\/eid2212.160718","article-title":"African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004\u20132014","volume":"22","author":"Weyer","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.005_b0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0264-410X(94)90052-3","article-title":"Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine","volume":"12","author":"House","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0090","first-page":"81","article-title":"Inactivated African horse sickness virus cell culture vaccine","volume":"14","author":"Mirchamsy","year":"1968","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2017.04.005_b0095","first-page":"311","article-title":"African horse-sickness killed-virus tissue culture vaccine","volume":"30","author":"Ozawa","year":"1966","journal-title":"Can J Comp Med Vet Sci"},{"key":"10.1016\/j.vaccine.2017.04.005_b0100","first-page":"177","article-title":"New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles","volume":"14","author":"Roy","year":"1998","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2017.04.005_b0105","first-page":"139","article-title":"Immune responses in a horse inoculated with the VP2 gene of African horsesickness virus","volume":"66","author":"Romito","year":"1999","journal-title":"The Onderstepoort J Veterinary Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0110","doi-asserted-by":"crossref","first-page":"e5997","DOI":"10.1371\/journal.pone.0005997","article-title":"Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA)","volume":"4","author":"Chiam","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.04.005_b0115","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.vaccine.2009.05.044","article-title":"Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus","volume":"27","author":"Guthrie","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0120","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2014.04.036","article-title":"Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge","volume":"32","author":"Alberca","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0125","doi-asserted-by":"crossref","first-page":"e16503","DOI":"10.1371\/journal.pone.0016503","article-title":"A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -\/- mouse model","volume":"6","author":"Castillo-Olivares","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.04.005_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2013.12.002","article-title":"Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation","volume":"180","author":"Calvo-Pinilla","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2015.01.009","article-title":"Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge","volume":"116","author":"Calvo-Pinilla","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0140","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1016\/j.vaccine.2014.07.031","article-title":"Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus","volume":"32","author":"Kanai","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0145","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/MCB.5.12.3403","article-title":"Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques","volume":"5","author":"Chakrabarti","year":"1985","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2017.04.005_b0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jviromet.2007.02.016","article-title":"Rapid cDNA synthesis and sequencing techniques for the genetic study of bluetongue and other dsRNA viruses","volume":"143","author":"Maan","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.04.005_b0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/viro.1998.9290","article-title":"The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses","volume":"248","author":"Himly","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.04.005_b0160","first-page":"89","article-title":"Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model","volume":"49","author":"Lelli","year":"2013","journal-title":"Veterinaria Italiana"},{"key":"10.1016\/j.vaccine.2017.04.005_b0165","first-page":"55","article-title":"Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals","volume":"48","author":"Ronchi","year":"2012","journal-title":"Veterinaria Italiana"},{"key":"10.1016\/j.vaccine.2017.04.005_b0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven behandlung pharmakologischer reihenversuche","volume":"162","author":"Karber","year":"1931","journal-title":"Naunyn-Schmiedebergs Archiv fuer Experimentelle Pathologie und Pharmakologie"},{"key":"10.1016\/j.vaccine.2017.04.005_b0175","first-page":"139","article-title":"The isolation and identification of further antigenic types of African horse sickness virus","volume":"29","author":"Howell","year":"1962","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0180","first-page":"465","article-title":"Immunological types of horsesickness virus and their significance in immunization","volume":"27","author":"McIntosh","year":"1958","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2017.04.005_b0185","doi-asserted-by":"crossref","unstructured":"Maan S, Maan NS, Belaganahalli MN, Kumar A, Batra K, Rao PP, et al. Genome Sequence of Bluetongue Virus Type 2 from India: evidence for Reassortment between Outer Capsid Protein Genes. Genome announcements; 2015. p. 3.","DOI":"10.1128\/genomeA.00045-15"},{"key":"10.1016\/j.vaccine.2017.04.005_b0190","doi-asserted-by":"crossref","first-page":"e1005056","DOI":"10.1371\/journal.ppat.1005056","article-title":"Widespread reassortment shapes the evolution and epidemiology of bluetongue virus following European invasion","volume":"11","author":"Nomikou","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.04.005_b0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/tbed.12024","article-title":"African horse sickness outbreaks caused by multiple virus types in Ethiopia","volume":"61","author":"Aklilu","year":"2014","journal-title":"Transbound Emerg Diseases"},{"issue":"255\u201364","key":"10.1016\/j.vaccine.2017.04.005_b0200","first-page":"65","article-title":"African horse sickness: a description of outbreaks in Namibia","volume":"45","author":"Scacchia","year":"2009","journal-title":"Veterinaria Italiana"},{"key":"10.1016\/j.vaccine.2017.04.005_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jviromet.2015.07.015","article-title":"Development of three triplex real-time reverse transcription PCR assays for the qualitative molecular typing of the nine serotypes of African horse sickness virus","volume":"223","author":"Weyer","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.04.005_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0034-5288(18)32261-6","article-title":"Clinical and serological response of sheep to serial challenge with different bluetongue virus types","volume":"34","author":"Jeggo","year":"1983","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2017.04.005_b0215","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1586\/14760584.3.4.S75","article-title":"Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors","volume":"3","author":"Franchini","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.04.005_b0220","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"Cottingham","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0225","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(01)00445-5","article-title":"The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant","volume":"20","author":"Scanlen","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.005_b0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/104063870802000310","article-title":"Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus","volume":"20","author":"Aguero","year":"2008","journal-title":"J Vet Diagn Invest"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T15:42:06Z","timestamp":1569080526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17304656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":46,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17304656"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}